Resilience, scepticism, and mRNA: The story of Katalin Karikó

Katalin Karikó mRNA vaccines for COVID-19

The COVID-19 pandemic presented the world’s governments and health organisations with a vaccination challenge on a scale it had never experienced before. Messenger RNA (mRNA) vaccines were critical in the production and distribution of affordable vaccines across the globe. Katalin Karikó’s 40 years of research into mRNA was the cornerstone of what made this possible. In this interview, we find […]

Read More… from Resilience, scepticism, and mRNA: The story of Katalin Karikó

Can we do more to get college students vaccinated against HPV?

Dr Roanna Kessler and John Gentile have developed a strategic toolkit for use on college campuses to encourage vaccination awareness for the HPV vaccine among college students

Human papillomavirus (HPV) is the most common sexually transmitted infection globally. It can cause genital warts and several types of cancer, including cervical, anal, penile, and throat cancer. Although an effective and safe vaccine against HPV infection has been available since 2006, the vaccination rates in the US remain low. The fact that more than 80% of sexually active people […]

Read More… from Can we do more to get college students vaccinated against HPV?

Clostridium difficile infection: Risk factors and potential vaccines

Antibiotics treatment is one of the main factors of risk for developing Clostridium difficile (C. diff) infection, a condition responsible for nearly 500,000 infections and 30,000 deaths each year in the U.S. alone. Dr Joseph Shiloach, Dr Ashish Sharma and their collaborators at the Biotechnology Core Laboratory of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) optimised […]

Read More… from Clostridium difficile infection: Risk factors and potential vaccines